本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1999/3/171 分钟阅读
Oral Dosage Form New Animal Drugs; Bacitracin Methylene Disalicylate Soluble
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for using soluble bacitracin methylene disalicylate (BMD) powder to make a medicated drinking water for replacement chickens as an aid in the prevention and control of necrotic enteritis.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →